...
首页> 外文期刊>International journal of surgical pathology >Nasal NK/T Cell Lymphoma in Taiwan: A Clinicopathologic Study of 22 Cases, with Analysis of Histologic Subtypes, Epstein-Barr Virus LMP-1 Gene Association, and Treatment Modalities.
【24h】

Nasal NK/T Cell Lymphoma in Taiwan: A Clinicopathologic Study of 22 Cases, with Analysis of Histologic Subtypes, Epstein-Barr Virus LMP-1 Gene Association, and Treatment Modalities.

机译:台湾的鼻NK / T细胞淋巴瘤:22例临床病理研究,包括组织学亚型,爱泼斯坦-巴尔病毒LMP-1基因关联和治疗方式的分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Nasal NK/T cell lymphoma is a distinctive type of extranodal lymphoma with an unique immunophenotype and a strong association with Epstein-Barr virus (EBV). It is one of the common extranodal lymphomas in Taiwan. We studied 22 cases of nasal NK/T cell lymphoma to characterize their clinicopathologic features and to explore the possible differences between histologic subtypes and their clinical behavior as well as the prevalence of 30-base pair (bp) deleted latent membrane protein-1 (LMP-1) gene of the EBV. They consisted of 5 cases of small cell type (SC), 6 cases of medium-sized cell type (MC), 6 cases of large cell type (LC), and 5 cases of pleomorphic cell type (PC). Twelve patients were men and 10 were women (1.2 to 1), and their ages ranged from 34 to 75 years with a median age of 55.5 years. The median ages of the LC type and PC type were older than the other 2 types. No other clinical features differed significantly among the 4 subtypes. Nasal obstruction was the most common initial presenting symptom. All but 1 case had stage IE disease at the time of diagnosis. Five cases developed extranasal involvement and skin was the most common site. No bone marrow involvement was detected. The majority of patients received local radiotherapy and chemotherapy. Local irradiation was more effective than chemotherapy alone. We achieved an overall survival of 63.6% at 5 years as estimated by the Kaplan-Meier analysis, which was better than other series. All cases displayed an immunophenotypic profile of CD3(epsilon)+, CD20-, CD56+, and TIA-1+ except that 1 case was CD3(epsilon)-. Fourteen of 22 cases (64%) expressed LMP-1. Nine cases of various cell types (41%) were also CD30+. Among the 4 histologic subtypes, the SC type differed from the other types by the absence of angiodestruction and necrosis, although angioinvasive growth was seen in 2 of them. Pseudoepitheliomatous hyperplasia was seen in only 3 cases of the SC type, and all 5 cases of the SC type were CD30-. No statistical difference in survival was found among the 4 histologic subtypes or between CD30+ and CD30- cases. All 22 cases were positive for EBV by polymerase chain reaction and Epstein-Barr virus early RNA (EBER) in-situ hybridization. A high prevalence rate of 86% (19/22) of the 30-base pair (bp) deleted LMP-1 gene was found, but 81.5% (22/27) of the EBV-positive control reactive lymphoid tissues also had the 30-bp deleted LMP-1 gene. Therefore, the high prevalence of the 30-bp deleted LMP-1 gene found in NK/T cell lymphoma could be due to the high prevalence of the deleted variant in this geographic region. However, it remains possible that the high prevalence of the deleted LMP-1 gene contributed to the increased incidence of EBV-associated nasal NK/T cell lymphoma in Taiwan. Int J Surg Pathol 12(4):375-387, 2004.
机译:鼻NK / T细胞淋巴瘤是结外淋巴瘤的一种独特类型,具有独特的免疫表型,并且与爱泼斯坦-巴尔病毒(EBV)有很强的联系。它是台湾常见的结外淋巴瘤之一。我们研究了22例鼻NK / T细胞淋巴瘤的临床病理特征,探讨了组织学亚型与临床行为之间的可能差异,以及30碱基对(bp)缺失的潜伏膜蛋白1(LMP)的患病率-1)EBV基因。他们包括5例小细胞类型(SC),6例中型细胞类型(MC),6例大细胞类型(LC)和5例多形细胞类型(PC)。男12例,女10例(1.2至1),年龄在34至75岁之间,中位年龄为55.5岁。 LC型和PC型的中位年龄比其他两种类型的年龄大。在这四种亚型之间,其他临床特征无明显差异。鼻梗阻是最常见的初始症状。在诊断时,除1例外,其他所有患者均患有IE期疾病。五例发生鼻外受累,皮肤是最常见的部位。没有检测到骨髓受累。大多数患者接受了局部放疗和化疗。局部照射比单纯化疗更有效。根据Kaplan-Meier分析估计,我们在5年时的总体生存率为63.6%,这比其他系列要好。除1例为CD3ε-外,所有病例均显示CD3ε+,CD20-,CD56 +和TIA-1 +的免疫表型特征。 22例病例中有14例(64%)表达了LMP-1。 9种不同细胞类型的病例(41%)也是CD30 +。在这4种组织学亚型中,SC型与其他类型的区别在于没有血管形成和坏死,尽管其中2种可见血管浸润性生长。仅3例SC型病例可见假性上皮瘤样增生,而SC型5例全部为CD30-。在这4种组织学亚型之间或CD30 +和CD30-病例之间,未发现生存率的统计学差异。通过聚合酶链反应和爱泼斯坦-巴尔病毒早期RNA(EBER)原位杂交,所有22例EBV均为阳性。发现30个碱基对(bp)缺失的LMP-1基因的高患病率是86%(19/22),但是EBV阳性对照反应性淋巴组织的30.5%(22/27)也有30 -bp缺失的LMP-1基因。因此,在NK / T细胞淋巴瘤中发现的30 bp缺失LMP-1基因的高流行可能是由于该地理区域中缺失变异的高流行。但是,仍有可能台湾缺失的LMP-1基因的高流行导致了EBV相关的鼻NK / T细胞淋巴瘤发病率的上升。 Int J Surg Pathol 12(4):375-387,2004。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号